List of Tables
Table 1. Global Point-of-care Testing (POCT) for Tumor Marker Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Point-of-care Testing (POCT) for Tumor Marker Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Point-of-care Testing (POCT) for Tumor Marker Market Competitive Situation by Manufacturers in 2024
Table 4. Global Point-of-care Testing (POCT) for Tumor Marker Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Point-of-care Testing (POCT) for Tumor Marker Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Point-of-care Testing (POCT) for Tumor Marker Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Point-of-care Testing (POCT) for Tumor Marker Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Point-of-care Testing (POCT) for Tumor Marker Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Point-of-care Testing (POCT) for Tumor Marker, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Point-of-care Testing (POCT) for Tumor Marker, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Point-of-care Testing (POCT) for Tumor Marker, Product Type & Application
Table 12. Global Key Manufacturers of Point-of-care Testing (POCT) for Tumor Marker, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Point-of-care Testing (POCT) for Tumor Marker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Testing (POCT) for Tumor Marker as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Point-of-care Testing (POCT) for Tumor Marker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Point-of-care Testing (POCT) for Tumor Marker Sales by Region (2020-2025) & (K Units)
Table 18. Global Point-of-care Testing (POCT) for Tumor Marker Sales Market Share by Region (2020-2025)
Table 19. Global Point-of-care Testing (POCT) for Tumor Marker Sales by Region (2026-2031) & (K Units)
Table 20. Global Point-of-care Testing (POCT) for Tumor Marker Sales Market Share by Region (2026-2031)
Table 21. Global Point-of-care Testing (POCT) for Tumor Marker Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Point-of-care Testing (POCT) for Tumor Marker Revenue Market Share by Region (2020-2025)
Table 23. Global Point-of-care Testing (POCT) for Tumor Marker Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Point-of-care Testing (POCT) for Tumor Marker Revenue Market Share by Region (2026-2031)
Table 25. North America Point-of-care Testing (POCT) for Tumor Marker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Point-of-care Testing (POCT) for Tumor Marker Sales by Country (2020-2025) & (K Units)
Table 27. North America Point-of-care Testing (POCT) for Tumor Marker Sales by Country (2026-2031) & (K Units)
Table 28. North America Point-of-care Testing (POCT) for Tumor Marker Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Point-of-care Testing (POCT) for Tumor Marker Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Point-of-care Testing (POCT) for Tumor Marker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Point-of-care Testing (POCT) for Tumor Marker Sales by Country (2020-2025) & (K Units)
Table 32. Europe Point-of-care Testing (POCT) for Tumor Marker Sales by Country (2026-2031) & (K Units)
Table 33. Europe Point-of-care Testing (POCT) for Tumor Marker Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Point-of-care Testing (POCT) for Tumor Marker Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Point-of-care Testing (POCT) for Tumor Marker Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Point-of-care Testing (POCT) for Tumor Marker Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Point-of-care Testing (POCT) for Tumor Marker Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Point-of-care Testing (POCT) for Tumor Marker Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Point-of-care Testing (POCT) for Tumor Marker Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Point-of-care Testing (POCT) for Tumor Marker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Point-of-care Testing (POCT) for Tumor Marker Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Point-of-care Testing (POCT) for Tumor Marker Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Point-of-care Testing (POCT) for Tumor Marker Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Point-of-care Testing (POCT) for Tumor Marker Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Point-of-care Testing (POCT) for Tumor Marker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Point-of-care Testing (POCT) for Tumor Marker Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Point-of-care Testing (POCT) for Tumor Marker Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Point-of-care Testing (POCT) for Tumor Marker Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Point-of-care Testing (POCT) for Tumor Marker Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Point-of-care Testing (POCT) for Tumor Marker Sales (K Units) by Type (2020-2025)
Table 51. Global Point-of-care Testing (POCT) for Tumor Marker Sales (K Units) by Type (2026-2031)
Table 52. Global Point-of-care Testing (POCT) for Tumor Marker Sales Market Share by Type (2020-2025)
Table 53. Global Point-of-care Testing (POCT) for Tumor Marker Sales Market Share by Type (2026-2031)
Table 54. Global Point-of-care Testing (POCT) for Tumor Marker Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Point-of-care Testing (POCT) for Tumor Marker Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Point-of-care Testing (POCT) for Tumor Marker Revenue Market Share by Type (2020-2025)
Table 57. Global Point-of-care Testing (POCT) for Tumor Marker Revenue Market Share by Type (2026-2031)
Table 58. Global Point-of-care Testing (POCT) for Tumor Marker Price (US$/Unit) by Type (2020-2025)
Table 59. Global Point-of-care Testing (POCT) for Tumor Marker Price (US$/Unit) by Type (2026-2031)
Table 60. Global Point-of-care Testing (POCT) for Tumor Marker Sales (K Units) by Application (2020-2025)
Table 61. Global Point-of-care Testing (POCT) for Tumor Marker Sales (K Units) by Application (2026-2031)
Table 62. Global Point-of-care Testing (POCT) for Tumor Marker Sales Market Share by Application (2020-2025)
Table 63. Global Point-of-care Testing (POCT) for Tumor Marker Sales Market Share by Application (2026-2031)
Table 64. Global Point-of-care Testing (POCT) for Tumor Marker Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Point-of-care Testing (POCT) for Tumor Marker Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Point-of-care Testing (POCT) for Tumor Marker Revenue Market Share by Application (2020-2025)
Table 67. Global Point-of-care Testing (POCT) for Tumor Marker Revenue Market Share by Application (2026-2031)
Table 68. Global Point-of-care Testing (POCT) for Tumor Marker Price (US$/Unit) by Application (2020-2025)
Table 69. Global Point-of-care Testing (POCT) for Tumor Marker Price (US$/Unit) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Point-of-care Testing (POCT) for Tumor Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche Point-of-care Testing (POCT) for Tumor Marker Product
Table 74. Roche Recent Developments/Updates
Table 75. Abbott Company Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Point-of-care Testing (POCT) for Tumor Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Abbott Point-of-care Testing (POCT) for Tumor Marker Product
Table 79. Abbott Recent Developments/Updates
Table 80. BioMerieux Company Information
Table 81. BioMerieux Description and Business Overview
Table 82. BioMerieux Point-of-care Testing (POCT) for Tumor Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. BioMerieux Point-of-care Testing (POCT) for Tumor Marker Product
Table 84. BioMerieux Recent Developments/Updates
Table 85. Wondfo Biotech Company Information
Table 86. Wondfo Biotech Description and Business Overview
Table 87. Wondfo Biotech Point-of-care Testing (POCT) for Tumor Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Wondfo Biotech Point-of-care Testing (POCT) for Tumor Marker Product
Table 89. Wondfo Biotech Recent Developments/Updates
Table 90. Yuwell Company Information
Table 91. Yuwell Description and Business Overview
Table 92. Yuwell Point-of-care Testing (POCT) for Tumor Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Yuwell Point-of-care Testing (POCT) for Tumor Marker Product
Table 94. Yuwell Recent Developments/Updates
Table 95. Getein Biotech Company Information
Table 96. Getein Biotech Description and Business Overview
Table 97. Getein Biotech Point-of-care Testing (POCT) for Tumor Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Getein Biotech Point-of-care Testing (POCT) for Tumor Marker Product
Table 99. Getein Biotech Recent Developments/Updates
Table 100. Beijing Wantai BioPharm Company Information
Table 101. Beijing Wantai BioPharm Description and Business Overview
Table 102. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Tumor Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Tumor Marker Product
Table 104. Beijing Wantai BioPharm Recent Developments/Updates
Table 105. Assure Tech Company Information
Table 106. Assure Tech Description and Business Overview
Table 107. Assure Tech Point-of-care Testing (POCT) for Tumor Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Assure Tech Point-of-care Testing (POCT) for Tumor Marker Product
Table 109. Assure Tech Recent Developments/Updates
Table 110. Randox Company Information
Table 111. Randox Description and Business Overview
Table 112. Randox Point-of-care Testing (POCT) for Tumor Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Randox Point-of-care Testing (POCT) for Tumor Marker Product
Table 114. Randox Recent Developments/Updates
Table 115. Orient Gene Company Information
Table 116. Orient Gene Description and Business Overview
Table 117. Orient Gene Point-of-care Testing (POCT) for Tumor Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Orient Gene Point-of-care Testing (POCT) for Tumor Marker Product
Table 119. Orient Gene Recent Developments/Updates
Table 120. Hangzhou Biotest Company Information
Table 121. Hangzhou Biotest Description and Business Overview
Table 122. Hangzhou Biotest Point-of-care Testing (POCT) for Tumor Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Hangzhou Biotest Point-of-care Testing (POCT) for Tumor Marker Product
Table 124. Hangzhou Biotest Recent Developments/Updates
Table 125. Shenzhen YHLO Company Information
Table 126. Shenzhen YHLO Description and Business Overview
Table 127. Shenzhen YHLO Point-of-care Testing (POCT) for Tumor Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Shenzhen YHLO Point-of-care Testing (POCT) for Tumor Marker Product
Table 129. Shenzhen YHLO Recent Developments/Updates
Table 130. Qingdao Hightop Biotech Co., Ltd. Company Information
Table 131. Qingdao Hightop Biotech Co., Ltd. Description and Business Overview
Table 132. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Tumor Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Tumor Marker Product
Table 134. Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
Table 135. Getein Biotech, Inc. Company Information
Table 136. Getein Biotech, Inc. Description and Business Overview
Table 137. Getein Biotech, Inc. Point-of-care Testing (POCT) for Tumor Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Getein Biotech, Inc. Point-of-care Testing (POCT) for Tumor Marker Product
Table 139. Getein Biotech, Inc. Recent Developments/Updates
Table 140. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Company Information
Table 141. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Description and Business Overview
Table 142. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Tumor Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Tumor Marker Product
Table 144. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Point-of-care Testing (POCT) for Tumor Marker Distributors List
Table 148. Point-of-care Testing (POCT) for Tumor Marker Customers List
Table 149. Point-of-care Testing (POCT) for Tumor Marker Market Trends
Table 150. Point-of-care Testing (POCT) for Tumor Marker Market Drivers
Table 151. Point-of-care Testing (POCT) for Tumor Marker Market Challenges
Table 152. Point-of-care Testing (POCT) for Tumor Marker Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Point-of-care Testing (POCT) for Tumor Marker
Figure 2. Global Point-of-care Testing (POCT) for Tumor Marker Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Point-of-care Testing (POCT) for Tumor Marker Market Share by Type: 2024 & 2031
Figure 4. Based on Immunochromatography Product Picture
Figure 5. Based on Chemiluminescence Technology Product Picture
Figure 6. Based on Biosensor Product Picture
Figure 7. Others Product Picture
Figure 8. Global Point-of-care Testing (POCT) for Tumor Marker Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Point-of-care Testing (POCT) for Tumor Marker Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. lndependent Testing Organization
Figure 12. Global Point-of-care Testing (POCT) for Tumor Marker Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Point-of-care Testing (POCT) for Tumor Marker Market Size (2020-2031) & (US$ Million)
Figure 14. Global Point-of-care Testing (POCT) for Tumor Marker Sales (2020-2031) & (K Units)
Figure 15. Global Point-of-care Testing (POCT) for Tumor Marker Average Price (US$/Unit) & (2020-2031)
Figure 16. Point-of-care Testing (POCT) for Tumor Marker Report Years Considered
Figure 17. Point-of-care Testing (POCT) for Tumor Marker Sales Share by Manufacturers in 2024
Figure 18. Global Point-of-care Testing (POCT) for Tumor Marker Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Point-of-care Testing (POCT) for Tumor Marker Players: Market Share by Revenue in Point-of-care Testing (POCT) for Tumor Marker in 2024
Figure 20. Point-of-care Testing (POCT) for Tumor Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Point-of-care Testing (POCT) for Tumor Marker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Point-of-care Testing (POCT) for Tumor Marker Sales Market Share by Country (2020-2031)
Figure 23. North America Point-of-care Testing (POCT) for Tumor Marker Revenue Market Share by Country (2020-2031)
Figure 24. United States Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Point-of-care Testing (POCT) for Tumor Marker Sales Market Share by Country (2020-2031)
Figure 27. Europe Point-of-care Testing (POCT) for Tumor Marker Revenue Market Share by Country (2020-2031)
Figure 28. Germany Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Point-of-care Testing (POCT) for Tumor Marker Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Point-of-care Testing (POCT) for Tumor Marker Revenue Market Share by Region (2020-2031)
Figure 35. China Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Point-of-care Testing (POCT) for Tumor Marker Sales Market Share by Country (2020-2031)
Figure 43. Latin America Point-of-care Testing (POCT) for Tumor Marker Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Point-of-care Testing (POCT) for Tumor Marker Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Point-of-care Testing (POCT) for Tumor Marker Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Point-of-care Testing (POCT) for Tumor Marker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Point-of-care Testing (POCT) for Tumor Marker by Type (2020-2031)
Figure 53. Global Revenue Market Share of Point-of-care Testing (POCT) for Tumor Marker by Type (2020-2031)
Figure 54. Global Point-of-care Testing (POCT) for Tumor Marker Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Point-of-care Testing (POCT) for Tumor Marker by Application (2020-2031)
Figure 56. Global Revenue Market Share of Point-of-care Testing (POCT) for Tumor Marker by Application (2020-2031)
Figure 57. Global Point-of-care Testing (POCT) for Tumor Marker Price (US$/Unit) by Application (2020-2031)
Figure 58. Point-of-care Testing (POCT) for Tumor Marker Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
